Ligand Pharm (LGND): Congress and insider trades
Who in Congress and inside the company traded LGND, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Ligand Pharm (LGND) is a listed stock on NASDAQ.
- 2 members of Congress filed 4 buys and 1 sell of LGND, the latest published 2026-06-09 (9 June 2026).
- Insiders filed 0 open market buys worth $0 and 17 sells worth $25M, the latest filed 2026-09-14 (14 September 2026).
- Across 3 scored buys, Congress averaged +18.7% against the S&P 500 (SPY) over the 90 days after disclosure, with 100% of them ahead of the index. That result is too few trades to draw a conclusion.
- Data as of 2026-09-29 (29 September 2026).
Congress trades in LGND
as of 2026-06-09| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 9 Jun 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 10 | +10.5% |
| 8 Apr 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 35 | +43.2% |
| 16 Feb 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 29 | +2.4% |
| 16 Feb 2026 | Gil Cisneros (D-CA) | buy | 1K–15K | 39 | +2.4% |
| 4 Dec 2020 | Katherine Clark (D-MA) | sell | 1K–15K | 42 | n/a |
Nothing matches that search.
Insider trades in LGND
as of 2026-09-14| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 14 Sep 2026 | Zimmermann Martine | sell | 1,200 | $285.00 | $342K | n/a |
| 8 Sep 2026 | Reardon Andrew | sell | 5,000 | $286.09 | $1.4M | n/a |
| 14 Aug 2026 | Espinoza Octavio | sell | 31,641 | $292.06 | $9.2M | n/a |
| 14 Aug 2026 | Haas Jason | sell | 7,138 | $292.81 | $2.1M | n/a |
| 4 Aug 2026 | Reardon Andrew | sell | 5,000 | $288.99 | $1.4M | n/a |
| 6 Jul 2026 | Reardon Andrew | sell | 5,000 | $313.28 | $1.6M | n/a |
| 18 Jun 2026 | Sabba Stephen L | sell | 2,145 | $254.00 | $545K | n/a |
| 15 Jun 2026 | Haas Jason | sell | 6,461 | $255.58 | $1.7M | n/a |
| 12 Jun 2026 | Aryeh Jason | sell | 500 | $250.00 | $125K | n/a |
| 12 Jun 2026 | Aryeh Jason | sell | 4,500 | $250.00 | $1.1M | n/a |
| 12 Jun 2026 | LAMATTINA JOHN L | sell | 4,591 | $250.88 | $1.2M | n/a |
| 2 Jun 2026 | Reardon Andrew | sell | 5,000 | $227.06 | $1.1M | n/a |
| 4 May 2026 | Reardon Andrew | sell | 5,000 | $231.31 | $1.2M | n/a |
| 2 Apr 2026 | Reardon Andrew | sell | 5,000 | $201.24 | $1.0M | n/a |
| 2 Apr 2026 | KOZARICH JOHN W | sell | 467 | $202.23 | $94.4K | n/a |
| 31 Mar 2026 | LAMATTINA JOHN L | sell | 2,161 | $200.76 | $434K | n/a |
| 25 Mar 2026 | Sabba Stephen L | sell | 1,000 | $207.87 | $208K | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought LGND?
4 Congress buys by 2 members and 0 insider buys are on file. The tables on this page list every one.
Did buying LGND after a disclosure beat the market?
Across 3 scored buys, Congress averaged +18.7% against the S&P 500 (SPY) over the 90 days after disclosure, with 100% of them ahead of the index. That result is too few trades to draw a conclusion. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.